Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Hepatotoxicity

Liver fibrosis with methotrexate — an overestimated risk?

Nature Reviews Gastroenterology & Hepatology volume 20, pages 347–348 (2023)Cite this article

Subjects

A prospective study suggests that the risk of liver fibrosis with methotrexate treatment has been overestimated. The findings suggest the need to reconsider the intensive strategies and the screening tools that are recommended for monitoring liver fibrosis in patients receiving methotrexate.

Refers to Atallah, E. et al. Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated. J. Hepatol. https://doi.org/10.1016/j.jhep.2022.12.034 (2023).

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Proposed relationship between methotrexate treatment and liver fibrosis.

References

  1. Zachariae, H. Methotrexate side-effects. Br. J. Dermatol. 122 (Suppl. 36), 127–133 (1990).

    Article  PubMed  Google Scholar 

  2. Whiting-O’Keefe, Q. E., Fye, K. H. & Sack, K. D. Methotrexate and histologic hepatic abnormalities: a meta-analysis. Am. J. Med. 90, 711–716 (1991).

    Article  PubMed  Google Scholar 

  3. Arena, U. et al. Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis. Dig. Liver Dis. 44, 149–153 (2012).

    Article  CAS  PubMed  Google Scholar 

  4. Atallah, E. et al. Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated. J. Hepatol. https://doi.org/10.1016/j.jhep.2022.12.034 (2023).

    Article  PubMed  Google Scholar 

  5. Vali, Y. et al. Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: a systematic review and meta-analysis. J. Hepatol. 73, 252–262 (2020).

    Article  PubMed  Google Scholar 

  6. Selvaraj, E. A. et al. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis. J. Hepatol. 75, 770–785 (2021).

    Article  PubMed  Google Scholar 

  7. Warren, R. B. et al. British Association of Dermatologists’ guidelines for the safe and effective prescribing of methotrexate for skin disease 2016. Br. J. Dermatol. 175, 23–44 (2016).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unidad de Gestión Clínica de Enfermedades Digestivas, Instituto de Investigación Biomédica de Málaga-IBIMA-Plataforma BIONAND, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Malaga, Spain

    Raul J. Andrade

  2. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain

    Raul J. Andrade

  3. Faculty of Medicine, University of Iceland, Reykjavík, Iceland

    Einar S. Björnsson

  4. Department of Gastroenterology, Landspitali University Hospital Reykjavík, Reykjavík, Iceland

    Einar S. Björnsson

Authors
  1. Raul J. Andrade
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Einar S. Björnsson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raul J. Andrade.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Andrade, R.J., Björnsson, E.S. Liver fibrosis with methotrexate — an overestimated risk?. Nat Rev Gastroenterol Hepatol 20, 347–348 (2023). https://doi.org/10.1038/s41575-023-00782-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41575-023-00782-3

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing